Condition: Generalized Anxiety Disorder (GAD) · Sponsor: AbbVie
Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD. The purpose of this study is to assess how safe and effective ABBV-932 is when added to the antidepressant therapies in adult participants with GAD who have had an inadequate response ADTs. ABBV-932 is an investigational drug being developed for the adjunctive treatment of GAD. Participants will be randomly assigned to receive ABBV-932 or Placebo in addition to their currently prescribed ADTs. There is 1 in 3 chance of participants assigned to Placebo. Approximately 315 adult participants with GAD and inadequate response to ADTs will be enrolled in approximately 50 sites in the United States and Puerto Rico. Participants will receive oral capsules of ABBV-932 or matching placebo in addition to their prescribed ADT for 6 weeks and then will be followed for an additional 4 week follow-up period. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| University of Alabama - Huntsville Regional Medical Campus /ID# 267818 | Huntsville, Alabama, United States | Recruiting |
| Ima Clinical Research Phoenix (Alea) /ID# 275737 | Phoenix, Arizona, United States | Recruiting |
| Noble Clinical Research /ID# 267952 | Tucson, Arizona, United States | Completed |
| Advanced Research Center /ID# 267874 | Anaheim, California, United States | Recruiting |
| Axiom Research /ID# 267814 | Colton, California, United States | Recruiting |
| Sun Valley Research Center /ID# 267864 | Imperial, California, United States | Recruiting |
| Synergy San Diego /ID# 267879 | Lemon Grove, California, United States | Recruiting |
| Alliance for Research Alliance for Wellness /ID# 267911 | Long Beach, California, United States | Recruiting |
| NRC Research Institute DTLA /ID# 267832 | Los Angeles, California, United States | Recruiting |
| Excell Research /ID# 267918 | Oceanside, California, United States | Recruiting |
| Inland Psychiatric Medical Group /ID# 268598 | Temecula, California, United States | Recruiting |
| Sunwise Clinical Research /ID# 267863 | Walnut Creek, California, United States | Recruiting |
+ 40 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06846320